Neogen Chemicals Ltd is Rated Hold

1 hour ago
share
Share Via
Neogen Chemicals Ltd is rated 'Hold' by MarketsMojo, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 11 July 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing.
Neogen Chemicals Ltd is Rated Hold

Current Rating and Its Significance

MarketsMOJO’s 'Hold' rating for Neogen Chemicals Ltd indicates a neutral stance on the stock, suggesting that investors should neither aggressively buy nor sell at this juncture. This rating reflects a balance between the company’s strengths and weaknesses across several key parameters, including quality, valuation, financial trends, and technical indicators. The 'Hold' grade, with a Mojo Score of 50.0, implies that while the stock shows potential, caution is warranted due to certain financial and operational challenges.

Quality Assessment

As of 11 July 2026, Neogen Chemicals exhibits an average quality grade. The company’s ability to generate returns on equity remains modest, with an average Return on Equity (ROE) of 6.86%. This figure suggests limited profitability relative to shareholders’ funds, which may temper investor enthusiasm. Additionally, the company’s operating profit has grown at a compounded annual rate of 13.82% over the past five years, indicating moderate growth but not at a pace that excites growth-focused investors.

One notable concern is the company’s high Debt to EBITDA ratio of 10.16 times, signalling a low capacity to service its debt obligations comfortably. This elevated leverage poses risks, especially in volatile market conditions, and contributes to the cautious rating. Furthermore, Neogen Chemicals has reported negative profits for the last four consecutive quarters, with the latest six-month Profit After Tax (PAT) declining by 30.32% to ₹15.08 crores. Interest expenses have concurrently increased by 33.69% to ₹42.98 crores, further pressuring profitability.

Valuation Considerations

The valuation grade for Neogen Chemicals is classified as very expensive. Despite this, the stock currently trades at a discount relative to its peers’ historical average valuations, with an Enterprise Value to Capital Employed (EV/CE) ratio of 3.2. This suggests that while the company’s valuation is high compared to its own financial performance, it may offer some relative value within the specialty chemicals sector.

However, the company’s Return on Capital Employed (ROCE) remains low at 5.25% for the half-year period, which does not justify the premium valuation. Investors should weigh this disparity carefully, as paying a high price for low returns can limit upside potential.

Financial Trend Analysis

The financial trend for Neogen Chemicals is currently negative. The company’s profitability has deteriorated over recent quarters, with a significant decline in PAT and rising interest costs. Despite these headwinds, the stock has delivered robust market returns, with a 1-year return of 32.22% and a year-to-date gain of 76.70% as of 11 July 2026. This divergence between market performance and financial health suggests that investor sentiment may be driven by factors other than fundamental strength, such as sector momentum or technical buying.

Operating profit growth, while positive over the long term, has not translated into improved bottom-line results, highlighting operational challenges. The negative earnings trend and high leverage remain key concerns for investors assessing the stock’s medium to long-term prospects.

Technical Outlook

Technically, Neogen Chemicals is rated bullish. The stock has shown strong price momentum recently, with a 3-month return of 53.09% and a 6-month return of 84.22%. The one-day gain of 3.12% and one-week increase of 6.37% further underscore positive market sentiment. This bullish technical grade suggests that the stock may continue to attract short-term interest from traders and momentum investors.

However, technical strength should be balanced against the company’s fundamental challenges. Investors relying solely on price action may face risks if the underlying financial performance does not improve.

Summary for Investors

In summary, Neogen Chemicals Ltd’s 'Hold' rating reflects a nuanced view of the company’s current situation. While the stock benefits from strong recent price performance and a bullish technical outlook, its financial fundamentals present cautionary signals. The company’s average quality, very expensive valuation, negative financial trend, and high leverage suggest that investors should approach with measured expectations.

For investors, the 'Hold' rating advises maintaining existing positions rather than initiating new buys or selling off holdings. It is prudent to monitor upcoming quarterly results and any changes in debt servicing capacity or profitability before making significant portfolio adjustments.

Just announced: This Small Cap from Tyres & Allied with precise target price is our pick for the week. Get the pre-market insights that informed this selection!

  • - Just announced pick
  • - Pre-market insights shared
  • - Tyres & Allied weekly focus

Get Pre-Market Insights →

Looking Ahead

Investors should keep a close eye on Neogen Chemicals’ efforts to improve its debt profile and return to profitability. Any signs of stabilisation in earnings or reduction in interest burden could enhance the company’s outlook and potentially shift the rating in future assessments.

Meanwhile, the stock’s current valuation and financial metrics suggest that it is best suited for investors with a moderate risk appetite who are comfortable with a hold strategy while awaiting clearer signs of operational improvement.

Conclusion

Neogen Chemicals Ltd’s 'Hold' rating by MarketsMOJO, last updated on 25 May 2026, reflects a balanced view of the company’s prospects as of 11 July 2026. The stock’s average quality, expensive valuation, negative financial trend, and bullish technicals combine to form a cautious but not pessimistic outlook. Investors should consider these factors carefully when making portfolio decisions and remain attentive to forthcoming financial disclosures.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News